NASDAQ:PLXSPlexus Stock Price, Forecast & News

Plexus' stock was trading at $60.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PLXS shares have increased by 25.9% and is now trading at $76.37.
View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Plexus.

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Plexus.

Plexus Corp. (NASDAQ:PLXS) released its quarterly earnings results on Wednesday, July, 22nd. The technology company reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.45. The technology company earned $857.39 million during the quarter, compared to analyst estimates of $801.94 million. Plexus had a return on equity of 12.41% and a net margin of 3.55%.
View Plexus' earnings history.

Plexus updated its fourth quarter earnings guidance on Wednesday, July, 22nd. The company provided EPS guidance of $1.05 to $1.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.90. The company issued revenue guidance of $850 million to $890 million, compared to the consensus revenue estimate of $820.47 million.

6 brokerages have issued 1-year price objectives for Plexus' shares. Their forecasts range from $72.00 to $91.00. On average, they anticipate Plexus' stock price to reach $81.60 in the next year. This suggests a possible upside of 6.8% from the stock's current price.
View analysts' price targets for Plexus.

News stories about PLXS stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Plexus earned a news impact score of -1.7 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Plexus.

Plexus saw a decline in short interest in July. As of July 15th, there was short interest totaling 772,800 shares, a decline of 21.3% from the June 30th total of 981,700 shares. Based on an average trading volume of 226,800 shares, the short-interest ratio is presently 3.4 days. Currently, 2.7% of the company's stock are sold short.
View Plexus' Current Options Chain.

Some companies that are related to Plexus include Trimble (TRMB), IPG Photonics (IPGP), Jabil (JBL), Mercury Systems (MRCY), Fabrinet (FN), Sanmina (SANM), TTM Technologies (TTMI), Methode Electronics (MEI), Benchmark Electronics (BHE), CTS (CTS), Park Electrochemical (PKE), Neonode (NEON) and Key Tronic (KTCC).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), QUALCOMM (QCOM), Twitter (TWTR) and ConocoPhillips (COP).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus' stock is owned by many different institutional and retail investors. Top institutional investors include Chartwell Investment Partners LLC (1.00%), Assenagon Asset Management S.A. (0.45%), Meritage Portfolio Management (0.15%), Mackay Shields LLC (0.13%), Comerica Bank (0.11%) and State of Alaska Department of Revenue (0.09%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim.
View institutional ownership trends for Plexus.

PLXS stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, SG Americas Securities LLC, Vident Investment Advisory LLC, Vident Investment Advisory LLC, Monarch Capital Management Inc., and Nisa Investment Advisors LLC. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey, and Yong Jin Lim.
View insider buying and selling activity for Plexus.

PLXS stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Meritage Portfolio Management, Mackay Shields LLC, Chartwell Investment Partners LLC, Strs Ohio, Uncommon Cents Investing LLC, Duality Advisers LP, and Diversified Trust Co.
View insider buying and selling activity for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $76.37.

Plexus has a market capitalization of $2.23 billion and generates $3.16 billion in revenue each year. The technology company earns $108.62 million in net income (profit) each year or $3.43 on an earnings per share basis. Plexus employs 19,000 workers across the globe.

The official website for Plexus is www.plexus.com.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]